Metraipolis › archive › dc_26b257ba1869

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression - the PRIME-PRAXOL randomized controlled trial — Europe PMC PPR:PPR1110322

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR1110322
DOI
10.21203/rs.3.rs-7887410/v1
License (as archived)
solo-consultazione
Archived
2026-11-08T23:14:25.283Z
SHA-256 of the archived text
893c8f726dc71caa0261492a49b8ab05f4e84bdc58a4bb506c0b2f3c404a1868
Stable URL of this page
https://metraipolis.com/documento/dc_26b257ba1869

How to cite

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression - the PRIME-PRAXOL randomized controlled trial — Europe PMC PPR:PPR1110322 — Europe PMC, https://europepmc.org/article/PPR/PPR1110322 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_26b257ba1869 (Metraipolis archive dc_26b257ba1869, sha256 893c8f726dc71caa0261492a49b8ab05f4e84bdc58a4bb506c0b2f3c404a1868)
BibTeX
@misc{dc26b257ba1869,
  title = {Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression - the PRIME-PRAXOL randomized controlled trial — Europe PMC PPR:PPR1110322},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR1110322},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_26b257ba1869; sha256 893c8f726dc71caa0261492a49b8ab05f4e84bdc58a4bb506c0b2f3c404a1868},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1110322. Agents can read the archived copy with the MCP tool read_document.